Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07537387) titled 'A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha' on April 9.

Study Type: Observational

Primary Sponsor: xieqing

Condition: Chronic Hepatitis b

Intervention: Drug: PEG IFNa-2b monotherapy or combination therapy with NAs

Recruitment Status: Not recruiting

Date of First Enrollment: April 30, 2026

Target Sample Size: 10000

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07537387

Disclaimer: Curated by HT Syndication....